Cure My Disease

Don't miss your cure!

 Log in / Sign up

When chest surgery turns dangerous: what a decade of rare vascular injuries can teach surgeons

NCT ID NCT07100509

Knowledge-focused Sponsor: Caner İşevi, MD Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This study reviews 10 years of records from a single hospital to understand how often major blood vessel injuries happen during planned chest surgeries, what causes them, and how surgeons manage them in the moment. The goal is to identify patterns that could improve preoperative planning and surgical safety for future patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If patterns emerge, this could help surgeons better prevent and manage rare but life-threatening bleeding events during chest surgery.
What could go wrong
This is a small, single-center review of past cases — findings may not apply to other hospitals or surgical teams.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

11 people

The number who actually took part.

Started

Jan 2015

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This study includes adult patients who underwent elective thoracic surgical procedures between January 2015 and December 2024 at a single tertiary care academic center. The study population is limited to patients who experienced major intraoperative vascular injuries involving central thoracic vessels such as the subclavian artery or vein, brachiocephalic vein, innominate artery or vein, superior vena cava (SVC), or thoracic aorta. All included patients required immediate surgical intervention for bleeding control. The study is retrospective and descriptive in nature.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients who underwent elective thoracic surgery between January 2015 and December 2024 * Development of a major intraoperative vascular injury during surgery * Injury involving central vessels such as the subclavian artery or vein, brachiocephalic vein, innominate artery or vein, superior vena cava (SVC), or thoracic aorta * Availability of complete operative and postoperative medical records * Underwent surgical repair of the vascular injury (e.g., grafting, primary repair, ligation) Exclusion Criteria: * Patients undergoing emergency thoracic surgery * Injuries limited to pulmonary artery or its branches * Minor bleeding from peripheral vessels that did not require major intervention * Postoperative vascular complications (e.g., delayed hemorrhage, pseudoaneurysm) * Missing or incomplete operative records

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Intraoperative complications are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Blood Loss, Surgical Intraoperative Complications Vascular System Injuries

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Intraoperative complications Thoracic surgery Vascular injury

More trials for these conditions

Other studies related to the condition(s) this trial covers.